ISB News

ISB Annual Report: Catalyzing A Revolution

Annual Report 2016

ISB’s compass has always been oriented toward the future. Even when we reflect on the past year for each annual report, it’s always through the lens of what’s on the horizon. We are remarkably consistent in that regard, which is in no small part due to our president Dr. Lee Hood, whose vision is perpetually a decade – at least – ahead of everyone else.

In this year’s letter, Dr. Hood offers a treatise on the momentum that has tipped his every prediction into a new reality.

As we contemplate his vision for the future of healthcare and scientific wellness, we are reminded of the core values that tether our intrepid researchers to our common foundation as they explore the far reaches of scientific discovery: We cherish intellectual freedom, value collaboration, share what we learn, create roadmaps, and we expect to invent the future of human health, scientific wellness, and environmental sustainability.

What lies ahead is a stretch of this roadmap. Travel with us.

Read More

Recent Articles

  • Dr. Sean Gibbons Promoted to Associate Professor

    Dr. Sean Gibbons – an expert in microbial ecology and evolution, computational systems biology, the human gut microbiome and its impacts on health, and head of ISB’s Gibbons Lab – has been promoted to Associate Professor. “Sean’s achievements since joining ISB in 2018 as a Washington Research Foundation Distinguished Investigator have been spectacular,” ISB President Dr. Jim Heath said. “With his focus on the microbiome, he brought a whole new…

  • AmeriCorps Member Sara Calder Joins ISB as Systems Health and STEM Coordinator

    Sara Calder recently joined ISB as Systems Health and STEM Coordinator, and is our second-ever AmeriCorps member. In this Q&A, Calder shares her education journey, her future plans, and much more.

  • In First-of-Its-Kind Trial, Scientists Use CRISPR to Treat Cancer

    Scientists for the first time have used CRISPR to substitute a gene to treat patients with cancer. The remarkable findings were published in the journal Nature and presented at the Society for Immunotherapy of Cancer (SITC) 2022.